Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

XORTX Therapeutics (XRTX)

XORTX Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XRTX
DateTimeSourceHeadlineSymbolCompany
24/09/202411:12Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
24/09/202411:09Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
24/09/202411:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
24/09/202411:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
24/09/202411:03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
24/09/202411:03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/09/202421:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
13/09/202421:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
13/09/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
13/09/202412:00GlobeNewswire Inc.XORTX Announces Results of Annual and Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
12/09/202422:30GlobeNewswire Inc.XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&ANASDAQ:XRTXXORTX Therapeutics Inc
06/09/202422:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
06/09/202422:30GlobeNewswire Inc.XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
03/09/202417:30GlobeNewswire Inc.Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
29/08/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
29/08/202412:00GlobeNewswire Inc.XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine MetabolismNASDAQ:XRTXXORTX Therapeutics Inc
23/08/202413:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
23/08/202412:00GlobeNewswire Inc.XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
22/08/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
20/08/202420:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
20/08/202412:00GlobeNewswire Inc.XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024NASDAQ:XRTXXORTX Therapeutics Inc
12/07/202421:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
12/07/202421:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/06/202421:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/06/202421:18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/06/202421:17Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/06/202421:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/06/202421:14Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/06/202421:13Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/06/202421:12Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:XRTX

Your Recent History

Delayed Upgrade Clock